Silo Pharma (SILO) Receivables - Other (2020 - 2024)
Silo Pharma (SILO) has disclosed Receivables - Other for 5 consecutive years, with $9600.0 as the latest value for Q2 2024.
- Quarterly Receivables - Other changed N/A to $9600.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $9600.0 through Jun 2024, changed N/A year-over-year, with the annual reading at $9600.0 for FY2023, 59.73% up from the prior year.
- Expense - Property Taxes and Insurance hit $21100.0 in Q3 2024 for Silo Pharma, roughly flat from $21101.0 in the prior quarter.
- In the past five years, Expense - Property Taxes and Insurance ranged from a high of $33292.0 in Q1 2022 to a low of $3982.0 in Q2 2020.
- Historically, Expense - Property Taxes and Insurance has averaged $23207.9 across 5 years, with a median of $23448.0 in 2023.
- Biggest five-year swings in Receivables - Other: skyrocketed 155.32% in 2021 and later crashed 89.98% in 2022.
- Year by year, Receivables - Other stood at $23500.0 in 2020, then soared by 155.32% to $60000.0 in 2021, then plummeted by 89.98% to $6010.0 in 2022, then skyrocketed by 59.73% to $9600.0 in 2023, then changed by 0.0% to $9600.0 in 2024.
- Business Quant data shows Receivables - Other for SILO at $9600.0 in Q2 2024, $9600.0 in Q1 2024, and $9600.0 in Q4 2023.